EP1514548A3

Use of cloprostenol fluprostenol, and their analogues to treat glaucoma and ocular hypertension

Abstract

Disclosed is the use of cloprostenol, fluprostenol, their analogues and their pharmaceutically acceptable salts and esters for the treatment of glaucoma and ocular hypertension. Also disclosed are ophthalmic compositions comprising said compounds.

Term

Term ended

Projected expiry passed 3 August 2014, 12.1 years ago.

Every citation, both ways

Citations
Document	Relation	Office	Category	Cited during	Relevant claims
EP0364417A1	Cites	European Patent Office (EPO)	DX	Search report	1-36
DAVID F. WOODWARD ET AL.: "Intraocular pressure effects of slective prostanoid receptor agonists involve different receptor subtypes according to radioligand binding studies", J.LIPID.MEDIAT., vol. 6, no. 1-3, 1993, pages 545 - 553, XP002009581	Non-patent	–	–	Search report	–
WOODWARD D.F. ET AL.: "Definition of prostanoid receptor subtypes by radioligand binding and the effects of selective agonists on intraocular pressure", EXP.EYE RES., vol. 55, no. sup1, 1992, pages s91, XP002009582	Non-patent	–	–	Search report	–

56 members in 13 offices

This recordMember, by publication date3 more offices are in the list below

Members56

Family members, oldest first
Document	Office	Kind
CA2129287A1	Canada	A1	1995-02-04
EP0639563A2	European Patent Office (EPO)	A2	1995-02-22
AU6877994A	Australia	A	1995-02-23
JPH07165703A	Japan	A	1995-06-27
US5510383A	United States of America	A	1996-04-23
EP0639563A3	European Patent Office (EPO)	A3	1996-10-16
US5665773A	United States of America	A	1997-09-09
AU690120B2	Australia	B2	1998-04-23
JPH10182465A	Japan	A	1998-07-07
JP2791544B2	Japan	B2	1998-08-27
AU7748898A	Australia	A	1998-10-01
US5889052A	United States of America	A	1999-03-30
AU704670B2	Australia	B2	1999-04-29
HK1010717A1	Hong Kong, China	A1	1999-06-25
US6184250B1	United States of America	B1	2001-02-06
US2001023258A1	United States of America	A1	2001-09-20
US6344478B2	United States of America	B2	2002-02-05
CA2129287C	Canada	C	2002-05-14
US2002111381A1	United States of America	A1	2002-08-15
US6723748B2	United States of America	B2	2004-04-20
US2004198817A1	United States of America	A1	2004-10-07
EP0639563B1	European Patent Office (EPO)	B1	2005-01-12
AT286880T	Austria	T	2005-01-15
ATE286880T2	Austria	T2	2005-01-15
DE69434228D1	Germany	D1	2005-02-17
EP1514548A2	European Patent Office (EPO)	A2	2005-03-16
DK0639563T3	Denmark	T3	2005-03-21
EP1514548A3This record	European Patent Office (EPO)	A3	2005-04-06
JP3650258B2	Japan	B2	2005-05-18
PT639563E	Portugal	E	2005-05-31
SI0639563T1	Slovenia	T1	2005-06-30
ES2235158T3	Spain	T3	2005-07-01
HK1072716A1	Hong Kong, China	A1	2005-09-09
DE69434228T2	Germany	T2	2006-02-02
EP1920764A1	European Patent Office (EPO)	A1	2008-05-14
HK1111636A1	Hong Kong, China	A1	2008-08-15
EP1920764B1	European Patent Office (EPO)	B1	2012-05-16
DK1920764T3	Denmark	T3	2012-07-02
ES2385267T3	Spain	T3	2012-07-20
PT1920764E	Portugal	E	2012-07-20
SI1920764T1	Slovenia	T1	2012-08-31
LU92058I2	Luxembourg	I2	2012-10-08
EP1514548B1	European Patent Office (EPO)	B1	2014-02-26
DK1514548T3	Denmark	T3	2014-03-17
PT1514548E	Portugal	E	2014-04-22
SI1514548T1	Slovenia	T1	2014-04-30
ES2458493T3	Spain	T3	2014-05-05
ES2458493T8	Spain	T8	2014-08-27
EP0639563B2	European Patent Office (EPO)	B2	2015-09-30
LU92509I2	Luxembourg	I2	2015-10-21
DK0639563T4	Denmark	T4	2016-01-11
ES2235158T5	Spain	T5	2016-05-25
EP1920764B2	European Patent Office (EPO)	B2	2020-01-08
DK1920764T4	Denmark	T4	2020-03-16
SI1920764T2	Slovenia	T2	2020-03-31
ES2385267T5	Spain	T5	2020-07-21

134 legal events, as 17 offices reported them to INPADOC

Over the term

Point at a mark for the event

Events

Legal events, newest first
	Event	Code	Office
2017-09-26	Ep patent revokedRevokedECNC	ECNC	SE
2017-03-15	Revocation of the patentMA03	MA03	AT
2016-12-21	Patent revokedRevoked27W	27W	EP
2016-11-18	Patent revokedRevokedORIGINAL CODE: 0009271RDAG	RDAG	EP
2016-11-18	Information on the status of an ep patent application or granted ep patentGrantedSTATUS: PATENT REVOKEDSTAA	STAA	EP
2016-08-31	Opposition filed (corrected)OppositionR26	R26	EP
2016-08-15	Epo's revocation decision now finalR064	R064	DE
2016-08-15	Patent revoked by epoRevokedR103	R103	DE
2016-08-04	Communication despatched that patent is revokedRevokedORIGINAL CODE: EPIDOSNREV1RDAF	RDAF	EP
2016-07-29	Opposition data, opponent's data or that of the opponent's representative modifiedOppositionORIGINAL CODE: 0009299OPPOPLAB	PLAB	EP
2016-07-29	Information modified related to despatch of communication that patent is revokedRevokedORIGINAL CODE: EPIDOSCREV1RDAD	RDAD	EP
2016-07-29	Information deleted related to despatch of communication that patent is revokedRevokedORIGINAL CODE: EPIDOSDREV1RDAE	RDAE	EP
2016-07-15	Publication of translation of european patent specificationUEP	UEP	AT
2016-06-30	Application for supplementary protection certificate rejectedSPCR	SPCR	SI
2016-06-15	Withdrawal (renunciation) of an spcSPCW	SPCW	AT
2016-06-10	Other action affecting the existence or the validity of an industrial property rightAV	AV	FR
2016-06-08	Application to withdraw or offer to surrender a supplementary protection certificateCTFW	CTFW	GB
2016-05-25	Rejection of an spcSPCR	SPCR	LT
2016-05-18	Request for extension of supplementary protection certificate filed [paediatric extension]SPCE	SPCE	IE
2016-05-18	Supplementary protection certificate withdrawnWithdrawnSPCW	SPCW	IE
2016-05-13	Supplementary protection certificate withdrawnWithdrawnSPCW	SPCW	CH
2016-05-11	Complete withdrawal of an spc [supplementary protection certificate]SPCW	SPCW	FR
2016-05-09	Supplementary protection certificate (spc) withdrawn, refused or deemed withdrawnWithdrawnCTFW	CTFW	DK
2016-04-26	Application withdrawn or ip right abandonedWithdrawnR120	R120	DE
2016-04-26	Application withdrawn or ip right abandoned [spc]WithdrawnS120	S120	DE
2016-03-30	Opposition filed (corrected)OppositionR26	R26	EP
2016-02-26	Opposition data, opponent's data or that of the opponent's representative modifiedOppositionORIGINAL CODE: 0009299OPPOPLAB	PLAB	EP
2016-02-25	Supplementary protection certificate (spc) grantedGrantedSPCG	SPCG	IT
2015-11-11	Filing application for a paediatric extension of a supplementary protection certificateSPCE	SPCE	NL
2015-11-11	Application for a supplementary protection certificateSPCF	SPCF	NL
2015-07-24	Reply of patent proprietor to notice(s) of opposition receivedOppositionORIGINAL CODE: EPIDOSNOBS3PLBB	PLBB	EP
2015-06-26	Annual fee for spc paid [supplementary protection certificate]SPAY	SPAY	FR
2015-05-13	Information modified related to communication of a notice of opposition and request to file observations + time limitOppositionORIGINAL CODE: EPIDOSCOBS2PLAF	PLAF	EP
2015-05-12	Application for supplementary protection certificate rejectedSPCR	SPCR	SE
2015-03-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2015-02-25	Filing an extension of an spc (for paediatric medicaments)SPCE	SPCE	LT
2015-01-30	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2015-01-16	Publication of the application to prolongate an spcSPCJ	SPCJ	FR
2015-01-14	Notice of opposition and request to file observation + time limit sentOppositionORIGINAL CODE: EPIDOSNOBS2PLAX	PLAX	EP
2015-01-08	Application for an extension of the duration (medicinal product for paediatric use)R420	R420	DE
2014-12-31	Opposition filedOpposition26	26	EP
2014-12-31	Opposition filedOpposition26	26	EP
2014-12-31	Opposition filedOpposition26	26	EP
2014-12-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2014-12-31	Request for extension of supplementary protection certificate filed [paediatric extension]SPCE	SPCE	IE
2014-12-31	Application for extension of supplementary protection certificate filedSPCE	SPCE	SI
2014-12-23	Application for extension of supplementary protection certificate filedSPCE	SPCE	SE
2014-12-18	Request for extension of a supplementary protection certificate for medicationSPCY	SPCY	FR
2014-12-17	Request for extension of supplementary protection certificate filed [paediatric extension]SPCY	SPCY	GB
2014-12-10	Filing application for a paediatric extension of a supplementary protection certificateSPCE	SPCE	NL
2014-11-28	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2014-11-28	Opposition filedOppositionORIGINAL CODE: 0009260PLBI	PLBI	EP
2014-11-25	Application for an extension of the duration (medicinal product for paediatric use)R420	R420	DE
2014-11-20	Announcement of lapse in spainLapsedFD2A	FD2A	ES
2014-10-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2014-10-23	Right expiredExpiredMA	MA	GR
2014-10-22	Patent expired after termination of 20 yearsExpiredPE20	PE20	GB
2014-10-17	Standard patents granted in hong kongGrantedGR	GR	HK
2014-10-15	Supplementary protection certificate filedPRODUCT NAME: TRAVOPROST; REGISTRATION NO/DATE: SWISSMEDIC 55910 22.05.2002SPCF	SPCF	CH
2014-10-10	Supplementary protection certificate (spc) filedCP	CP	FR
2014-09-30	Ep patent has lapsedLapsedEUG	EUG	SE
2014-09-24	Patent expiredExpiredMK9A	MK9A	IE
2014-09-15	ExpiryMK07	MK07	AT
2014-09-11	Application for supplementary protection certificate effectively filedR065	R065	DE
2014-09-08	Application for supplementary protection certificate (spc) filedCTFF	CTFF	DK
2014-08-31	Be: patent expiredExpiredBE20	BE20	EP
2014-08-29	Application for supplementary protection certificate filedSPCF	SPCF	SI
2014-08-27	Request for grant of supplementary protection certificateSPCF	SPCF	IE
2014-08-25	Filing an spcSPCF	SPCF	LT
2014-08-20	Supplementary protection certificate filedCTFF	CTFF	GB
2014-08-19	Application for supplementary protection certificate filedSPCF	SPCF	SE
2014-08-15	Patent ceasedCeasedPL	PL	CH
2014-08-13	Discontinued because of reaching the maximum lifetime of a patentV4	V4	NL
2014-08-12	Annulment/lapse due to non-payment of fees, searched and examined patentLapsedMAXIMUM VALIDITY LIMIT REACHEDMM4A	MM4A	PT
2014-08-05	Application for supplementary protection certificate effectively filedR065	R065	DE
2014-08-05	Change of applicant/patenteeR081	R081	DE
2014-08-05	Change of applicant/patenteeR081	R081	DE
2014-08-05	Change of representativeR082	R082	DE
2014-08-05	Change of applicant/patentee [supplementary protection certificate]SP81	SP81	DE
2014-08-05	Change of representative [supplementary protection certificate]SP82	SP82	DE
2014-08-04	Ep patent expiredExpiredEUP	EUP	DK
2014-07-30	Supplementary protection certificate (spc) filedSPCF	SPCF	IT
2014-07-24	Supplementary protection certificate (spc) filedCP	CP	FR
2014-06-17	Translation of granted ep patentGrantedTRGR	TRGR	SE
2014-06-04	Grant of a supplementary protection certificateKC1	KC1	NL
2014-05-22	Ep patent validated in greeceEP	EP	GR
2014-05-08	Opposition filed against patentOppositionR026	R026	DE
2014-05-05	Definitive protectionFG2A	FG2A	ES
2014-04-23	Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)REGISTERED BETWEEN 20140327 AND 20140402732E	732E	GB
2014-04-22	Translation is availableAVAILABILITY OF NATIONAL TRANSLATIONSC4A	SC4A	PT
2014-04-10	Dpma publication of mentioned ep patent grantGrantedR096	R096	DE
2014-04-09	European patents granted designating irelandGrantedFG4D	FG4D	IE
2014-04-04	Other action affecting the ownership or exploitation of an industrial property rightAU	AU	FR
2014-04-04	Concession to grant licencesCL	CL	FR
2014-04-02	Opposition filedOpposition26	26	EP
2014-04-01	Translation filed for an european patent granted for nl, confirming art. 52 par. 1 or 6 of the patents act 1995GrantedT3	T3	NL
2014-03-17	Ep patent with danish claimsT3	T3	DK
2014-03-15	Reference to at number (ep patent validated in austria)REF	REF	AT
2014-02-28	European patent takes effect as a national patent in ch/liEP	EP	CH
2014-02-28	New agentNV	NV	CH

Showing 100 of 134

Use of cloprostenol fluprostenol, and their analogues to treat glaucoma and ocular hypertension

Abstract

Term

Members56

Over the term

Events

Numbers

Titles3

Classification

Designated states19